References
- Balharry D, Oreffo V, Richards R. (2005). Use of toxicogenomics for identifying genetic markers of pulmonary oedema. Toxicol Appl Pharmacol 204:101–8.
- Chua F, Gauldie J, Laurent GJ. (2005). Pulmonary fibrosis: searching for model answers. Am J Respir Cell Mol Biol 33:9–13.
- Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, Chen J, Chow B, Chui C, Crowley C, Currell B, Deuel B, Dowd P, Eaton D, Foster J, Grimaldi C, Gu Q, Hass PE, Heldens S, Huang A, Kim HS, Klimowski L, Jin Y, Johnson S, Lee J, Lewis L, Liao D, Mark M, Robbie E, Sanchez C, Schoenfeld J, Seshagiri S, Simmons L, Singh J, Smith V, Stinson J, Vagts A, Vandlen R, Watanabe C, Wieand D, Woods K, Xie MH, Yansura D, Yi S, Yu G, Yuan J, Zhang M, Zhang Z, Goddard A, Wood WI, Godowski P, Gray A. (2003). The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res 13:2265–70.
- Demedts M, Wells AU, Anto JM, Costabel U, Hubbard R, Cullinan P, Slabbynck H, Rizzato G, Poletti V, Verbeken EK, Thomeer MJ, Kokkarinen J, Dalphin JC, Taylor AN. (2001). Interstitial lung diseases: an epidemiological overview. Eur Respir J Suppl 32:2s–16s.
- Dempsey OJ. (2006). Clinical review: idiopathic pulmonary fibrosis–past, present and future. Respir Med 100:1871–85.
- Evans JP. (2002). The molecular basis of sperm-oocyte membrane interactions during mammalian fertilization. Hum Reprod Update 8:297–311.
- Fellrath JM, du Bois RM. (2003). Idiopathic pulmonary fibrosis/ cryptogenic fibrosing alveolitis. Clin Exp Med 3:65–83.
- Kaplan F, Ledoux P, Kassamali FQ, Gagnon S, Post M, Koehler D, Deimling J, Sweezey NB. (1999). A novel developmentally regulated gene in lung mesenchyme: homology to a tumor-derived trypsin inhibitor. Am J Physiol 276:L1027–36.
- Miserocchi G, Negrini D, Passi A, De Luca G. (2001). Development of lung edema: interstitial fluid dynamics and molecular structure. News Physiol Sci 16:66–71.
- Nagai A, Aoshiba K, Ishihara Y, Inano H, Sakamoto K, Yamaguchi E, Kagawa J, Takizawa T. (1992). Administration of alpha 1- proteinase inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am Rev Respir Dis 145:651–6.
- Ookuma S, Fukuda M, Nishida E. (2003). Identification of a DAF-16 transcriptional target gene, scl-1, that regulates longevity and stress resistance in Caenorhabditis elegans. Curr Biol 13:427–31.
- Richards JS. (2005). Ovulation: new factors that prepare the oocyte for fertilization. Mol Cell Endocrinol 234:75–9.
- Shen AS, Haslett C, Feldsien DC, Henson PM, Cherniack RM. (1988). The intensity of chronic lung inflammation and fibrosis after bleomycin is directly related to the severity of acute injury. Am Rev Respir Dis 137:564–71.
- Smith DM, Collins-Racie LA, Marigo VA, Roberts DJ, Davis NM, Hartmann C, Schweitzer R, LaVallie ER, Gamer L, McCoy J, Tabin CJ. (2001). Cloning and expression of a novel cysteine-rich secreted protein family member expressed in thyroid and pancreatic mesoderm within the chicken embryo. Mech Dev 102:223–6.
- Trexler M, Banyai L, Patthy L. 2000. The LCCL module. Eur J Biochem 267:5751–7.
- Wolfensohn S, Lloyd M. (1998). Practical use of distress scoring systems in the application of humane endpoints. In: Handbook of Laboratory Animal Management and Welfare, 2nd ed. Oxford: Blackwell Science. p. 48–53.